Resveratrol deacetylates SIRT1 and activates hepatic Liver Kinase B1 (LKB1), leading to an increase in AMPK activity, which stimulates energy catabolism and improves cellular NAD+ levels, resulting in cancer inhibition 224. The gene discussed is STK11; the disease is cancer.